tenk.fyi

Tarsus Pharmaceuticals, Inc.

TARSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$451.4M

146.7% YoY

Net Income

-$66.4M

42.5% YoY

EPS

$-1.59

48.2% YoY

Cash

$183.6M

93.7% YoY

FY 2025 · As of 2025-12-31